本页面由Tiger Trade Technology Pte. Ltd.提供服务

Zenas BioPharma Inc.

25.30
-1.1000-4.17%
成交量:31.49万
成交额:815.79万
市值:16.49亿
市盈率:-2.79
高:27.00
开:26.11
低:25.04
收:26.40
52周最高:44.60
52周最低:13.50
股本:6,517.67万
流通股本:4,502.47万
量比:0.71
换手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-9.0522
每股收益(LYR):-8.4448
净资产收益率:-199.04%
总资产收益率:-34.42%
市净率:6.67
市盈率(LYR):-3.00

数据加载中...

2026/10/13

重要事件披露

Form 8-K - Current report
2026/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/27

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/27

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/26

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/16

重要事件披露

Form 8-K - Current report
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/05

重要事件披露

Form 8-K - Current report
2025/12/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/16

重要事件披露

Form 8-K - Current report